![]() |
Volumn 5, Issue 5, 2017, Pages 327-328
|
Theory and Fact: Revisiting Association and Causation
|
Author keywords
biomarkers; endothelin; endothelin antagonists; prognosis
|
Indexed keywords
BIOLOGICAL MARKER;
BOSENTAN;
ENDOTHELIN 1;
PLACEBO;
ANTIHYPERTENSIVE AGENT;
ENDOTHELIN RECEPTOR ANTAGONIST;
ADRENERGIC SYSTEM;
BLOOD PRESSURE;
CARDIAC MUSCLE CELL;
CARDIOVASCULAR MORTALITY;
CORONARY ARTERY BLOOD FLOW;
CRITICALLY ILL PATIENT;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG TOLERABILITY;
EDITORIAL;
EXPERIMENTAL AUTOIMMUNE MYOCARDITIS;
FLUID RETENTION;
HEART FAILURE;
HEART HEMODYNAMICS;
HIGH RISK PATIENT;
HOSPITAL READMISSION;
HOSPITALIZATION;
HUMAN;
HYPOTENSION;
KIDNEY CORTEX;
KIDNEY PROXIMAL TUBULE;
NONHUMAN;
OBESITY;
OUTCOME ASSESSMENT;
PREDICTION;
PROGNOSIS;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
ANTIHYPERTENSIVE AGENTS;
ENDOTHELIN RECEPTOR ANTAGONISTS;
HEART FAILURE;
HUMANS;
|
EID: 85018678907
PISSN: 22131779
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchf.2017.03.005 Document Type: Editorial |
Times cited : (2)
|
References (6)
|